Magnetar Financial’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Magnetar Financial's TGTX Position: Q3 2026 in Review
Magnetar Financial opened a new position in TG Therapeutics (TGTX) in Q3 2026: 12,068 shares worth $673K. The stake represents 0.01% of the portfolio and ranks #701 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in TGTX as recently as Q1 2026.
Magnetar Financial first reported a position in TGTX in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.07M in Q2 2023. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Magnetar Financial held 12,068 shares of TG Therapeutics worth $673K as of Q3 2026.
- TG Therapeutics was a new Magnetar Financial position in Q3 2026.
- TG Therapeutics made up 0.01% of Magnetar Financial's portfolio in Q3 2026, its #701 holding.
- Magnetar Financial first reported a position in TG Therapeutics in Q2 2021 and has held it in 8 quarters since.
- Magnetar Financial's TG Therapeutics position peaked at $1.07M in Q2 2023.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.